These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15517845)

  • 1. Modafinil as adjunctive therapy in depressed outpatients.
    Nasr S
    Ann Clin Psychiatry; 2004; 16(3):133-8. PubMed ID: 15517845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study.
    DeBattista C; Doghramji K; Menza MA; Rosenthal MH; Fieve RR;
    J Clin Psychiatry; 2003 Sep; 64(9):1057-64. PubMed ID: 14628981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue.
    Ninan PT; Hassman HA; Glass SJ; McManus FC
    J Clin Psychiatry; 2004 Mar; 65(3):414-20. PubMed ID: 15096082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study.
    Thase ME; Fava M; DeBattista C; Arora S; Hughes RJ
    CNS Spectr; 2006 Feb; 11(2):93-102. PubMed ID: 16520686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open-label study of adjunctive modafinil in patients with sedation related to serotonergic antidepressant therapy.
    Schwartz TL; Azhar N; Cole K; Hopkins G; Nihalani N; Simionescu M; Husain J; Jones N
    J Clin Psychiatry; 2004 Sep; 65(9):1223-7. PubMed ID: 15367049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective trial of modafinil as an adjunctive treatment of major depression.
    DeBattista C; Lembke A; Solvason HB; Ghebremichael R; Poirier J
    J Clin Psychopharmacol; 2004 Feb; 24(1):87-90. PubMed ID: 14709953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
    Black J; Houghton WC
    Sleep; 2006 Jul; 29(7):939-46. PubMed ID: 16895262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness.
    Fava M; Thase ME; DeBattista C
    J Clin Psychiatry; 2005 Jan; 66(1):85-93. PubMed ID: 15669893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome.
    Black JE; Hirshkowitz M
    Sleep; 2005 Apr; 28(4):464-71. PubMed ID: 16171291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coadministration of modafinil and a selective serotonin reuptake inhibitor from the initiation of treatment of major depressive disorder with fatigue and sleepiness: a double-blind, placebo-controlled study.
    Dunlop BW; Crits-Christoph P; Evans DL; Hirschowitz J; Solvason HB; Rickels K; Garlow SJ; Gallop RJ; Ninan PT
    J Clin Psychopharmacol; 2007 Dec; 27(6):614-9. PubMed ID: 18004129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective chart review of the effects of modafinil on depression as monotherapy and as adjunctive therapy.
    Price CS; Taylor FB
    Depress Anxiety; 2005; 21(4):149-53. PubMed ID: 16035049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptoms of fatigue and sleepiness in major depressive disorder.
    Baldwin DS; Papakostas GI
    J Clin Psychiatry; 2006; 67 Suppl 6():9-15. PubMed ID: 16848671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy.
    Becker PM; Schwartz JR; Feldman NT; Hughes RJ
    Psychopharmacology (Berl); 2004 Jan; 171(2):133-9. PubMed ID: 14647965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open-label trial of modafinil augmentation in patients with partial response to antidepressant therapy.
    Markovitz PJ; Wagner S
    J Clin Psychopharmacol; 2003 Apr; 23(2):207-9. PubMed ID: 12640225
    [No Abstract]   [Full Text] [Related]  

  • 15. Open-label study of adjunct modafinil for the treatment of patients with fatigue, sleepiness, and major depression treated with selective serotonin reuptake inhibitors.
    Konuk N; Atasoy N; Atik L; Akay O
    Adv Ther; 2006; 23(4):646-54. PubMed ID: 17050507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A placebo-controlled evaluation of adjunctive modafinil in the treatment of bipolar depression.
    Frye MA; Grunze H; Suppes T; McElroy SL; Keck PE; Walden J; Leverich GS; Altshuler LL; Nakelsky S; Hwang S; Mintz J; Post RM
    Am J Psychiatry; 2007 Aug; 164(8):1242-9. PubMed ID: 17671288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modafinil : a review of its use in excessive sleepiness associated with obstructive sleep apnoea/hypopnoea syndrome and shift work sleep disorder.
    Keating GM; Raffin MJ
    CNS Drugs; 2005; 19(9):785-803. PubMed ID: 16142993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness.
    Fava M; Thase ME; DeBattista C; Doghramji K; Arora S; Hughes RJ
    Ann Clin Psychiatry; 2007; 19(3):153-9. PubMed ID: 17729016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modafinil augmentation of antidepressant treatment in depression.
    Menza MA; Kaufman KR; Castellanos A
    J Clin Psychiatry; 2000 May; 61(5):378-81. PubMed ID: 10847314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of adjunctive modafinil on wakefulness and quality of life in patients with excessive sleepiness-associated obstructive sleep apnoea/hypopnoea syndrome: a 12-month, open-label extension study.
    Hirshkowitz M; Black J
    CNS Drugs; 2007; 21(5):407-16. PubMed ID: 17447828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.